跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ccc
首页
药物
ccc
ccc
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
UNSYMMETRICAL SALTS, CCC-NHC PINCER METAL COMPLEXES, AND METHODS OF MAKING THE SAME
申请人: UNIV MISSISSIPPI STATE
优先权: 2017
CN
EP
US
WO
7 件公开
Application of micromolecule RNA tRF-1: 31-Gly-CCC-3 in preparation of anti-osteoporosis drugs
申请人: UNIV SHANDONG
优先权: 2024
CN
2 件公开
Application of micromolecule RNA tRF-1: 29-Gly-CCC-1-M4 in preparation of medicine for resisting aging of mesenchymal stem cells
申请人: UNIV SHANDONG
优先权: 2024
CN
2 件公开
Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy(pac)
申请人: CCC DIAGNOSTICS LLC
优先权: 2005
CN
COMPREHENSIVE DIAGNOSTIC TESTING PROCEDURES FOR PERSONALIZED ANTICANCER CHEMOTHERAPY (PAC)
申请人: CCC DIAGNOSTICS LLC
优先权: 2006
US
Neutrophile granulocyte membrane mediated tRF-GlyCCC nanoparticles and application thereof in preparation of products for preventing and treating aortic dissection
申请人: UNIV QINGDAO
优先权: 2024
CN
Preparation method and application of amifostine complex lipid nanoparticles
申请人: UNIV CHANGZHOU
优先权: 2024
CN
Antisense Oligonucleotide to Inhibit Melanoma Inhibitory Activity Mia
申请人: SCHLINGENSIEPEN KARL-HERMANN
优先权: 2003
US
2 件公开
药物
反馈